Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Rapid Dose Therapeutics Corp
C.DOSE
Alternate Symbol(s):
RDTCF
Cannabis
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream...
, resulting in rapid onset of the active ingredient. It has one operating segment comprising production, distribution, research, and the provision of technical services for the delivery of oral thin film strips containing active ingredients. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:DOSE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
(7)
•••
bajanjohn
X
View Profile
View Bullboard History
Post by
bajanjohn
on Nov 21, 2022 7:28pm
Audits.........
Hopefully they will finally under promise and over deliver.....time will tell, and as a friend of mine always says "the proof is in the puddin"
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 21, 2022 7:04am
New Press Release - Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to work diligently to complete...
read article.
(7)
•••
bajanjohn
X
View Profile
View Bullboard History
Comment by
bajanjohn
on Nov 10, 2022 6:47pm
RE:Retail expansion
Thats great but how about something other than "aunt Marys store, like a "Major" retailer as well as on the other side of the equation, where is some "REAL" medicine in the
...more
(7)
•••
bajanjohn
X
View Profile
View Bullboard History
Post by
bajanjohn
on Nov 10, 2022 6:42pm
Projected filings
Two weeks MANDATED update and the projected date is two weeks later, does someone there need a crystal ball to determine when the will be ready? It just seems that they have no blinking idea as
...more
(2175)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Nov 09, 2022 3:12pm
Retail expansion
Where to Find QuickStrip™ Products in Retail Locations RDT’s QuickStrip
...more
(27)
•••
Luckierjack2
X
View Profile
View Bullboard History
Comment by
Luckierjack2
on Nov 08, 2022 5:34am
RE:RE:RE:RE:RE:RE:More delays in financials
You're right. They just delayed the financials again. Now November 30.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 07, 2022 6:01pm
New Press Release - Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to work diligently to complete...
read article.
(12)
•••
Mykndrsn
X
View Profile
View Bullboard History
Comment by
Mykndrsn
on Nov 07, 2022 5:46pm
RE:RE:RE:RE:RE:More delays in financials
The puppy has been killed by incompetence. Can't be resuscitated.
(27)
•••
Luckierjack2
X
View Profile
View Bullboard History
Comment by
Luckierjack2
on Nov 05, 2022 6:45am
RE:RE:RE:RE:More delays in financials
I not sure how they save this puppy, but why do you say it's over? LJ
(12)
•••
Mykndrsn
X
View Profile
View Bullboard History
Comment by
Mykndrsn
on Nov 04, 2022 10:33am
RE:RE:RE:More delays in financials
It's all over.
(27)
•••
Luckierjack2
X
View Profile
View Bullboard History
Comment by
Luckierjack2
on Nov 03, 2022 12:47pm
RE:RE:More delays in financials
My guess is that the financial statments will be disappointing at best, but time will tell. They can't raise money with their stock halted. Good luck to all longs LJ
(12)
•••
Mykndrsn
X
View Profile
View Bullboard History
Comment by
Mykndrsn
on Nov 03, 2022 9:19am
RE:More delays in financials
This pathetic excuse for a going concern has absolutely no one in management capable of leading this company. Period. Sad for the bag holders who were conned, sadly more than just freinds of relatives
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 24, 2022 6:01pm
New Press Release - Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to work diligently to complete...
read article.
(27)
•••
Luckierjack2
X
View Profile
View Bullboard History
Post by
Luckierjack2
on Oct 12, 2022 11:53am
More delays in financials
On Sept 26, 2022, Dose says they will file by October 15, 2022. On October 12, 2022, they now say October 31, 2022. Let's get the financials done and filed. Good luck to all
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 12, 2022 9:50am
New Press Release - Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated September 12, 2022, the Company and its auditors are continuing to work diligently to complete...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario